反应详情

(S)-4-(2-(2-(6-(tert-butoxycarbonylamino)-1-oxoisoindolin-2-yl)acetoxy)-2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)ethyl)-3,5-dichloropyridine 1-oxide (70 mg, 0.099 mmol) was dissolved in HCl 4M in ethyl acetate (1.5 ml, 49.4 mmol). The reaction was stirred at RT for 2 hours. The reaction mixture was concentrated under vacuum, the crude product was triturated with Et2O and filtered to give (S)-4-(2-(2-(6-amino-1-oxoisoindolin-2-yl)acetoxy)-2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)ethyl)-3,5-dichloropyridine 1-oxide (60 mg, 0.099 mmol, quantitative yield). 1H NMR (400 MHz, acetone) δ ppm 8.33 (s, 2H), 7.68-7.94 (m, 3H), 7.16-7.32 (m, 2H), 7.06 (dd, J=8.19, 1.83 Hz, 1H), 6.93 (t, 1H, CHF2), 6.12-6.23 (m, 1H), 4.61 (s, 2H), 4.46 (d, J=3.18 Hz, 2H), 3.99 (dd, J=6.85, 1.22 Hz, 2H), 3.57 (d, J=9.78 Hz, 1H), 3.37 (d, J=4.65 Hz, 1H), 1.22-1.37 (m, 1H), 0.54-0.68 (m, 2H), 0.40 (d, J=4.65 Hz, 2H); MS/ESI+ 608.42 [MH]+.

1. concentrationThe reaction mixture was concentrated under vacuum
2. customthe crude product was triturated with Et2O
3. filtrationfiltered